A Robust LC-MS/MS Method for Sensitive and Accurate Determination of N-Nitroso Fluoxetine in Fluoxetine Oral Solution

In the world of medicine, the safety of a pill or a liquid depends not just on the active ingredient that heals, but on what else might be hiding inside the bottle. Even tiny amounts of unintended chemicals, known as impurities, can sometimes cause serious harm. Among the most worrying of these are a class of compounds called nitrosamines. These substances are known to damage DNA and can lead to cancer, even when present in trace amounts. Because of this, health regulators around the world have become extremely strict about monitoring them in drugs. One common antidepressant, fluoxetine, which is often prescribed to help manage depression and anxiety, has been identified as a chemical that could potentially react during storage or manufacturing to form a specific type of nitrosamine called N-Nitroso fluoxetine. If this happens, the medicine could become unsafe for patients. The challenge for scientists is that detecting these dangerous traces is incredibly difficult; they are like finding a single grain of sand in a large pile of flour, requiring tools that are both incredibly sensitive and precise enough to distinguish the harmful grain from the harmless flour.

To address this challenge, a team of researchers developed a new, highly reliable method to find and measure N-Nitroso fluoxetine in liquid fluoxetine medicine. They used a sophisticated technique called liquid chromatography-tandem mass spectrometry, which acts like a multi-stage filter and detector system. First, the liquid medicine is passed through a special column that separates its different chemical components based on how they interact with the column's surface. Then, as the chemicals exit the column, they enter a mass spectrometer, a machine that weighs molecules and breaks them apart to identify them by their unique mass. The researchers tuned this system to look specifically for the mass signature of the dangerous nitrosamine impurity, ignoring everything else. They tested this approach on a commercial version of fluoxetine oral solution, a liquid form of the drug containing 20 milligrams of the active ingredient in every 5 milliliters. The goal was to create a method that could not only find the impurity if it was there but also measure exactly how much was present, down to the smallest possible amount.

The results of their work were highly successful. The team proved that their method could detect the impurity at levels as low as 0.152 parts per million, which is the limit of detection, and could accurately measure it starting from 0.398 parts per million, known as the limit of quantification. To put this sensitivity in perspective, the method is capable of spotting the impurity at a level far below what is considered safe, ensuring that even the tiniest traces would not go unnoticed. When they tested the method's ability to measure the same sample repeatedly, the results were consistent, with very little variation between tests. They also checked if the method could distinguish the impurity from the other ingredients in the medicine, such as the flavorings and preservatives, and found that the machine saw only the target impurity, with no confusion from the rest of the mixture. This confirmed that the method is specific and will not give false alarms.

Beyond just finding the impurity, the researchers needed to ensure the method was accurate and robust enough for daily use in a quality control lab. They tested this by adding known amounts of the impurity to the medicine and seeing if their method could measure those amounts correctly. The results showed that the method recovered between 107 and 110 percent of the added impurity, a range that indicates high accuracy. They also tested whether the method worked well when different people performed the tests on different days or with different equipment, and the results remained consistent, proving the method is reliable under various conditions. Furthermore, they checked if the liquid samples would stay stable over time in the refrigerator and whether the filters used to clean the samples before testing would accidentally trap the impurity. The samples remained stable for over 30 hours, and the filters did not remove any of the impurity, meaning the measurement would not be skewed by the preparation process.

The study concludes that this new analytical tool is ready for routine use to ensure the safety of fluoxetine oral solutions. By providing a way to detect and measure N-Nitroso fluoxetine with high precision and sensitivity, the method gives pharmaceutical manufacturers and regulators a powerful way to monitor their products. This ensures that the medicine reaching patients is free from these harmful contaminants, maintaining the highest standards of safety. The work represents a significant step forward in the ongoing effort to keep medicines pure and safe, demonstrating that with the right tools, even the most elusive and dangerous impurities can be brought to light and controlled.